Cargando…
Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate
BACKGROUND: Pregnant women with systemic lupus erythematosus (SLE) have increased risk of adverse outcomes including disease flare, spontaneous abortion, preeclampsia/eclampsia, premature birth and maternal death. However, pregnancy outcomes among adolescents and young women with SLE have not been w...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902884/ https://www.ncbi.nlm.nih.gov/pubmed/29661199 http://dx.doi.org/10.1186/s12969-018-0242-0 |
_version_ | 1783314834080661504 |
---|---|
author | Ling, Nicole Lawson, Erica von Scheven, Emily |
author_facet | Ling, Nicole Lawson, Erica von Scheven, Emily |
author_sort | Ling, Nicole |
collection | PubMed |
description | BACKGROUND: Pregnant women with systemic lupus erythematosus (SLE) have increased risk of adverse outcomes including disease flare, spontaneous abortion, preeclampsia/eclampsia, premature birth and maternal death. However, pregnancy outcomes among adolescents and young women with SLE have not been well-explored. Our objective was to compare risk of adverse pregnancy outcomes in adolescents and young women with SLE to risk among peers without SLE. METHODS: We studied the 2000–2011 Nationwide Inpatient Sample (NIS) of the Healthcare Cost and Utilization Project (HCUP) to estimate the prevalence of adverse pregnancy outcomes in women with SLE aged ≤ 21 years at time of delivery. Outcomes were compared to peers without SLE by using multivariate logistic regression to calculate odds ratios and risk differences. Additionally, differences in length of stay and total charges per hospitalization were described. RESULTS: There were 8,791,391 unique pregnancies, of which 4002 occurred in young women with SLE. After adjustment for age, race, insurance type and quartile of median income based on patient ZIP code individuals with SLE had increased odds of pre-eclampsia/eclampsia (OR 3.2, 95% CI 2.3–4.6), maternal death (OR 80, 95% CI 10–604), preterm birth (OR 2.7, 95% CI 2–3.7), spontaneous abortion (OR 5.1, 95% CI 2.8–9.6), and induced abortion (OR 30, 95% CI 14–63). The increase in risk among women with SLE was greatest for preterm birth (RD 11%, 95% CI 6–16), pre-eclampsia/eclampsia (RD 9%, 95% CI 5–13), and spontaneous abortion (RD 4%, 95% CI 0.9–6). Risk difference for induced abortion was 2% with 95% CI 0.6–4, while the difference in risk for maternal death did not reach statistical significance (RD 0.4, 95% CI -0.4-1). CONCLUSIONS: Adolescents and young women with SLE experience increased risk of adverse, pregnancy-specific outcomes as compared to their peers, including pre-eclampsia/eclampsia, maternal death, preterm birth, spontaneous abortion, and induced abortion. Additionally, length of stay and total charges for hospitalization are increased. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12969-018-0242-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5902884 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-59028842018-04-23 Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate Ling, Nicole Lawson, Erica von Scheven, Emily Pediatr Rheumatol Online J Research Article BACKGROUND: Pregnant women with systemic lupus erythematosus (SLE) have increased risk of adverse outcomes including disease flare, spontaneous abortion, preeclampsia/eclampsia, premature birth and maternal death. However, pregnancy outcomes among adolescents and young women with SLE have not been well-explored. Our objective was to compare risk of adverse pregnancy outcomes in adolescents and young women with SLE to risk among peers without SLE. METHODS: We studied the 2000–2011 Nationwide Inpatient Sample (NIS) of the Healthcare Cost and Utilization Project (HCUP) to estimate the prevalence of adverse pregnancy outcomes in women with SLE aged ≤ 21 years at time of delivery. Outcomes were compared to peers without SLE by using multivariate logistic regression to calculate odds ratios and risk differences. Additionally, differences in length of stay and total charges per hospitalization were described. RESULTS: There were 8,791,391 unique pregnancies, of which 4002 occurred in young women with SLE. After adjustment for age, race, insurance type and quartile of median income based on patient ZIP code individuals with SLE had increased odds of pre-eclampsia/eclampsia (OR 3.2, 95% CI 2.3–4.6), maternal death (OR 80, 95% CI 10–604), preterm birth (OR 2.7, 95% CI 2–3.7), spontaneous abortion (OR 5.1, 95% CI 2.8–9.6), and induced abortion (OR 30, 95% CI 14–63). The increase in risk among women with SLE was greatest for preterm birth (RD 11%, 95% CI 6–16), pre-eclampsia/eclampsia (RD 9%, 95% CI 5–13), and spontaneous abortion (RD 4%, 95% CI 0.9–6). Risk difference for induced abortion was 2% with 95% CI 0.6–4, while the difference in risk for maternal death did not reach statistical significance (RD 0.4, 95% CI -0.4-1). CONCLUSIONS: Adolescents and young women with SLE experience increased risk of adverse, pregnancy-specific outcomes as compared to their peers, including pre-eclampsia/eclampsia, maternal death, preterm birth, spontaneous abortion, and induced abortion. Additionally, length of stay and total charges for hospitalization are increased. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12969-018-0242-0) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-16 /pmc/articles/PMC5902884/ /pubmed/29661199 http://dx.doi.org/10.1186/s12969-018-0242-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Ling, Nicole Lawson, Erica von Scheven, Emily Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate |
title | Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate |
title_full | Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate |
title_fullStr | Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate |
title_full_unstemmed | Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate |
title_short | Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate |
title_sort | adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902884/ https://www.ncbi.nlm.nih.gov/pubmed/29661199 http://dx.doi.org/10.1186/s12969-018-0242-0 |
work_keys_str_mv | AT lingnicole adversepregnancyoutcomesinadolescentsandyoungwomenwithsystemiclupuserythematosusanationalestimate AT lawsonerica adversepregnancyoutcomesinadolescentsandyoungwomenwithsystemiclupuserythematosusanationalestimate AT vonschevenemily adversepregnancyoutcomesinadolescentsandyoungwomenwithsystemiclupuserythematosusanationalestimate |